Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
dabigatran vs rivaroxaban | 1.41 | 0.3 | 3167 | 63 | 25 |
dabigatran | 0.04 | 0.8 | 7357 | 35 | 10 |
vs | 1.64 | 0.2 | 6018 | 6 | 2 |
rivaroxaban | 0.85 | 0.8 | 5795 | 1 | 11 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
dabigatran vs rivaroxaban | 0.69 | 0.4 | 9548 | 26 |
dabigatran vs rivaroxaban mechanism of action | 1.74 | 0.3 | 7158 | 93 |
dabigatran vs apixaban vs rivaroxaban | 1.62 | 0.9 | 7554 | 4 |
switching from dabigatran to rivaroxaban | 1.6 | 0.4 | 7621 | 80 |
dabigatran rivaroxaban and apixaban | 1.14 | 0.6 | 608 | 41 |
mechanism of action of dabigatran | 1.53 | 0.1 | 8643 | 84 |
mechanism of action of rivaroxaban | 1.09 | 0.3 | 8979 | 88 |
apixaban dabigatran edoxaban and rivaroxaban | 0.08 | 0.1 | 8249 | 30 |
rivaroxaban mode of action | 1.42 | 1 | 4838 | 73 |
mode of action of dabigatran | 0.53 | 1 | 1898 | 88 |
dabigatran duration of action | 0.9 | 0.1 | 5856 | 3 |
rivaroxaban duration of action | 0.13 | 0.4 | 9961 | 46 |
rivaroxaban route of administration | 0.56 | 0.4 | 3411 | 84 |
dabigatran route of administration | 0.39 | 0.9 | 1261 | 80 |
therapeutic response of rivaroxaban | 1.99 | 0.9 | 7090 | 69 |
dual pathway inhibition rivaroxaban | 0.21 | 0.9 | 3771 | 91 |
dabigatran direct thrombin inhibitor | 1.27 | 0.4 | 5599 | 62 |
dabigatran drug interaction case report | 0.25 | 1 | 635 | 100 |
direct thrombin inhibitors dabigatran | 0.03 | 1 | 7464 | 88 |